IGF-I and E-cadherin in Breast Cancer Cells
Author Information
Author(s): M.E. Bracke, B.M. Vyncke, E.A. Bruyneel, S.J. Vermeulen, G.K. De Bruyn, N.A. Van Larebeke, K. Vleminckx, F.M. Van Roy, M.M. Mareel
Primary Institution: University Hospital, Gent, Belgium
Hypothesis
Does insulin-like growth factor I (IGF-I) activate the invasion suppressor role of E-cadherin in MCF-7 human mammary carcinoma cells?
Conclusion
IGF-I activates the invasion suppressor function of E-cadherin in MCF-7/6 cells, inhibiting their invasion.
Supporting Evidence
- IGF-I treatment led to homotypic aggregation of MCF-7/6 cells within 5 to 10 minutes.
- MCF-7/6 cells were invasive in organ culture without IGF-I treatment.
- Monoclonal antibodies against E-cadherin blocked the aggregation effect of IGF-I.
- Insulin mimicked the effects of IGF-I on cell aggregation but did not act through the IGF-I receptor.
Takeaway
This study found that a substance called IGF-I helps a protein called E-cadherin do its job better, which stops cancer cells from spreading.
Methodology
The study used immunofluorescence, flow cytometry, and organ culture assays to evaluate the effects of IGF-I on cell adhesion and invasion.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website